1. IRBshare: Streamlining IRB Review of Multisite Studies EMILY SHEFFER, MPA | VANDERBILT UNIVERSITY MEDICAL CENTER | EMILY.SHEFFER@IRBSHARE.ORG

2. IRBshare Background Funded by National Center for Research Resources (NCRR) (2011-2014) Initial Project Goals ◦Maintain high level of protection for human subjects in multicenter trials ◦Accelerate study start Up ◦Create a scalable IRB reliance model (minimal funding required; open to all institutions) ◦Create transparency between IRBs to promote shared expertise and practices >30 Institutions CTSA Leadership, IRB Directors, Lawyers, Clinical Trial Experts Sponsors Sponsors Eli Lily, NIH, VA Regulatory Expertise Regulatory Expertise OHRP, AAHRPP, WIRB

3. Shared Review Model 1.Local investigator submits study to local IRB 2.Study reviewed according to risk level (expedited or full committee review) upload 1.Local investigator submits study to local IRB (abbrev application recommended) 2.Study reviewed by local subcommittee (>1 IRB member) using IRBshare documents LEAD IRB LOCAL OVERSIGHT IRB Committee Responsibility: 1.Determine whether study meets all federal regulatory guidelines for approval of research (e.g., 45 CFR 46.111) Subcommittee Responsibility: 1.Verify (not re-review) Lead IRB’s determination, AND 2.Review for site’s own local context issues IRB application Consent form(s) (become model consent(s)) Protocol + IB/Device Manual Meeting minutes (redacted) Determination letter download LOCAL IRB MAINTAINS OVERSIGHT BUSINESS AS USUAL Initial Study Review Continuing Review Study-wide amendments

4. STEP 1: Lead IRB identified by PIs and/or sponsor or funder. Lead IRB may be 1st IRB with approval IRB of Overall Study PI AND should be a site at which all or most study activities occur STEP 6: Approved ICF sent to other sites (by same entity as used in 4a) STEP 3: PI at Lead IRB submits study to Local IRB AS USUAL STEP 4b: Lead IRB reviews study as usual STEP 5: Lead IRB approves study, notifies Lead PI as usual, and uploads approval to IRBshare System. Initiating Use of IRBshare STEP 7: Local PIs submit to their Local IRB, following their local submission guidelines for IRBshare (see 4a). Study PIs discuss alternative Lead IRB options with other IRBs, if any. STEP 2: Site PI contacts IRBshare Liaison* with request to be Lead IRB YES NO *IRBshare Liaisons are the primary IRB contact at each siteIRBshare Liaisons Alternative Lead IRB Identified STEP 8: Local IRBs use Shared Review Process to approve study and note reliance on Lead IRB’s approval in IRBshare System. Study Teams IRBs STEP 4a: Notify* other site PIs with instructions to: Ask local IRB about submission procedures (e.g., use of abbreviated application); Wait to submit to their IRB until Lead IRB PI shares approved Informed Consent Form (ICF) *Whoever is coordinating study (e.g., Coordinating center, CRO, PI at Lead IRB, etc.) STEP 9: Local IRBs send approval letter to local investigator (note: letter may note of IRBshare). Local IRB remains IRB of record for local PI. ALL SITE PIs report local modifications, AEs, unanticipated problems, etc. to local IRB. Follow protocol regarding adverse event reporting to other sites. Repeat Steps 3-9 for continuing review and study-wide amendments.

5. IRBshare is NOT a Central IRB How is it different? ◦Single IRB Review vs. Single IRB of Record ◦One review of criteria for approval of research ◦Local context is reviewed by each local IRB ◦IRBshare does not change to whom investigators submit and report: Always the Local IRB ◦Lead IRB grants approval for it’s local site only ◦Lead IRB does not receive submissions from all site investigators

6. Benefits for Investigators Accelerate study start up by avoiding multiple full committee reviews No budget required (many central IRBs require significant start up and operational funds) Fewer interactions and requests for changes from IRB Streamlined initial IRB submission for relying IRBs (per local IRB policy) Each investigator only reports to one IRB—their local IRB

7. Preliminary Results and Lessons Learned IRBSHARE MASTER AGREEMENT FINALIZED: OCTOBER 2012 FIRST RELIANCE: FEBRUARY 2013

8. IRBshare Scope and Eligibility  Institutions  Any institution with an FWA and federally constituted IRB  AAHRPP not required, but captured for relying sites’ decision making  Studies  All studies that require IRB review  All diseases and conditions  All funders: Federal, industry, and investigator-initiated  IRB Reviews Included  All Phase of Review: Initial study review, continuing review, and reviews of amendments

9. IRBshare Successes National Reliance Model: ◦62 institutions in 29 states ◦62 institutions in 29 states have executed single master reliance agreement ◦No funding required to support use Median of 14 days Accelerating Study Start Up: Median of 14 days from submission to approval (n=34 reliances; 65% studies are greater than minimal risk) Transparency ◦Shared Expertise—Institutions unable to transfer oversight can streamline their review ◦Shared Practices—IRBs communicating and sharing documents/templates

10. IRBshare Network (n=62) *AAHRPP accredited (n=46); †CTSA institution (n=39) States (n=29): Alabama Arizona Arkansas California Florida Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Massachusetts Michigan Mississippi Minnesota New Mexico New York North Carolina Ohio Oregon Pennsylvania South Carolina Tennessee Texas Utah Virginia West Virginia Washington (Washington DC) Baystate Health*Ohio UniversityUniversity of Cincinnati*† Boston University Medical Center*†Oregon Health & Science University†University of Illinois Chicago*† Children’s National Medical Center*†Pennington Biomedical Research Center*University of Iowa*† Cincinnati Children’s Hospital Medical Center*†St. Claire Regional Medical CenterUniversity of Kansas*† Columbia University*†Seattle Children’s HospitalUniversity of Kentucky*† Duke University*†Stanford University*†University of Miami† Louisiana State University A & M*Sutter West Bay HospitalsUniversity of New Mexico Health Sciences Center*† Indiana University*†Texas A&M UniversityUniversity of North Carolina at Chapel Hill *† Louisiana State University HSC New Orleans*The Rockefeller University*†University of Pennsylvania*† Louisiana State University HSC Shreveport*The Scripps Research Institute†University of Pittsburgh*† Maine Medical Center*The University of Arizona*University of Southern California*† Marshall University*The University of Texas HSC at Houston*†University of Texas HSC at San Antonio*† Medical University of South Carolina*†The University of Utah*†University of Texas Southwestern Medical Center† Mayo Clinic*†Tufts Medical Center†University of Washington† Meharry Medical College†Tufts University †Vanderbilt University*† Michigan State University*Tulane University*Virginia Commonwealth University*† Mississippi State University*University of Alabama Birmingham*†Wake Forest University Health Sciences* Mount Sinai Medical School*†University of Arkansas for Medical Sciences*†Washington University (St. Louis) *† New York University School of Medicine*†University of California, Los Angeles†*West Virginia University* North Shore LIH Health SystemUniversity of California, San Diego†Xavier University (Louisiana) Northwestern University †University of California, San Francisco*†

11. https://IRBshare.org